Morrison Jodie Pope 4
4 · Verve Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Morrison Jodie Pope
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-26+267,541→ 267,541 totalExercise: $5.02Exp: 2034-06-25→ Common Stock (267,541 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 26, 2027, subject to the Reporting Person's continued service as a director.